XML 39 R28.htm IDEA: XBRL DOCUMENT v3.19.2
Related Parties Transactions (Tables)
 6 Months Ended
Jun. 30, 2019
Related Party Transactions [Abstract]  
Schedule of related party transactions
Name of entity or Individual   Relationship with the Company and its subsidiaries
BioFirst Corporation (the "BioFirst")   Collaborative partners; Shareholder of the Company; Entity controlled by controlling beneficiary shareholder of YuanGene
BioFirst (Australia) Pty Ltd. (the "BioFirst (Australia)")   100% owned by BioFirst; Entity controlled by controlling beneficiary shareholder of YuanGene
LBG USA, Inc. (the "LBG USA")   100% owned by BioFirst; Entity controlled by controlling beneficiary shareholder of YuanGene
Lion Arts Promotion Inc. (the "LION")   Shareholder of the Company; Controlling shareholder of BioLite Inc.
LionGene Corporation (the "LionGene")   Shareholder of the Company; Entity controlled by controlling beneficiary shareholder of YuanGene
BioHopeKing Corporation (the "BHK")   Collaborative partners, BioLite Inc. owns 7.13% of BHK's common stock and serves as the Supervisor of BHK, Chi-Chou Liao, the Chairman of BHK, is also the shareholder of the Company.
Rgene Corporation (the "Rgene")   Collaborative partners; Shareholder of the Company; Entity controlled by controlling beneficiary shareholder of YuanGene
YuanGene Corporation (the "YuanGene")   Controlling beneficiary shareholder of the Company
AsiaGene Corporation (the "AsiaGene")   Shareholder of the Company; Entity controlled by controlling beneficiary shareholder of YuanGene
Keypoint Technology Ltd. (the "Keypoint')   The Chairman of Keypoint is Shu-Ling Jiang.
Yoshinobu Odaira (the "Odaira")   Director of the Company
GenePharm Inc. (the "GenePharm")   Mr. George Lee, the Director and Chairman of Biokey, is the Chairman of GenePharm.
Mr. Tsung-Shann Jiang, Ms. Shu-Ling Jiang, Mr. Chang-Jen Jiang, Ms. Mei-Ling Jiang, and Mr. Eugene Jiang (collectively the "Jiangs")  

Mr. Tsung-Shann Jiang, the controlling beneficiary shareholder of the Company and Rgene, the Chairman and CEO of the BioLite Holding Inc. and BioLite Inc. and the President and a member of board of directors of BioFirst

Ms. Shu-Ling Jiang, Mr. Tsung-Shann Jiang's wife, is the Chairman of Keypoint, LION, and BioFirst; and a member of board of directors of BioLite Inc.

Mr. Eugene Jiang is Mr. and Ms. Jiang's son. Mr. Eugene Jiang is the chairman, and majority shareholder of the Company and a member of board of directors of BioLite Inc.

Mr. Chang-Jen Jiang is Mr. Tsung-Shann Jiang's sibling and the director of the Company.

Ms. Mei-Ling Jiang is Ms. Shu-Ling Jiang's sibling.
Schedule of accounts receivable related parties

   June 30,   December 31, 
   2019   2018 
GenePharm Inc.  $142,225   $       - 
Total  $142,225   $- 
Schedule of due from related parties

   June 30,   December 31, 
   2019   2018 
Rgene Corporation  $25,025   $19,477 
AsiaGene Corporation   3,256    - 
BioFirst (Australia) Pty Ltd.   40,000    40,000 
BioHopeKing Corporation   111,780    - 
LBG USA Inc.   675    - 
Total  $180,736   $59,477 
Schedule of amount due to related party

   June 30,   December 31, 
   2019   2018 
Lion Arts Promotion Inc  $97,864   $65,495 
LionGene Corporation   428,099    458,348 
BioFirst Corporation   3,002,911    6,428,643 
AsiaGene Corporation   160,000    160,000 
YuanGene Corporation   92,690    92,690 
The Jiangs   1,198,729    539,920 
Total  $4,980,293   $7,745,096